Please login to the form below
Ebola disease
This page shows the latest Ebola disease news and features for those working in and with pharma, biotech and healthcare.
WHO launches R&D efforts to identify pathogens that could cause future pandemics
The list, which is not exhaustive, currently includes COVID-19, Crimean-Cong haemorrhagic fever, Ebola virus disease and Marburg virus disease, Lassa fever, Middle East respiratory syndrome (MERS) and severe acute ... respiratory syndrome (SARS), Nipah
Latest news
-
AbbVie, Amgen and Takeda team up for joint COVID-19 trial
Together, experts across our companies and industry can accelerate trials with promising, well-understood therapies that upon investigation, may show efficacy in this devastating disease," he added. ... This includes Gilead’s investigational antiviral
-
UPDATED: Gilead drops remdesivir’s orphan drug designation
Calling COVID-19 a rare disease mocks people’s suffering and exploits a loophole in the law to profiteer off a deadly pandemic,” it added. ... Remdesivir, originally developed as a treatment for Ebola virus disease, has been in the global spotlight
-
Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in US
Prior to the novel coronavirus outbreak, Gilead was evaluating remdesivir as a treatment for Ebola virus disease, but since the drug has also shown promise against other types of coronavirus – namely
-
Merck’s Ebola vaccine wins approval in four African countries
Merck became the first drug developer to win approval for an Ebola vaccine last year, from both the US Food and Drug Administration and the European Medicines Agency. ... The DRC is currently experiencing an outbreak of Ebola, with more than 2, 200 live
-
China’s BrightGene successfully copies Gilead’s coronavirus hopeful remdesivir
cases. In an attempt to stop the spread of the disease, researchers as well as Chinese health authorities have been testing a number of experimental therapies against COVID-19. ... The one with the most potential – so far – has been antiviral drug
More from news
Approximately 1 fully matching, plus 14 partially matching documents found.
Latest Intelligence
-
As COVID-19 takes over the world, biopharma fights back
Prior to the coronavirus outbreak, Gilead had primarily been focused on testing remdesivir’s potential in Ebola virus disease, although the antiviral also demonstrated promise in other coronaviruses, including severe acute ... Infectious disease expert
-
Communicating in a crisis
For example about 600, 000 people die of heart disease in the US each year, according to the Centers for Disease Control and Prevention, yet Ebola has taken the headlines. ... But for Lund, when discussing a united front to contain and eradicate Ebola,
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- BeiGene’s Brukinsa receives FDA approval for chronic lymphocytic leukaemia
- Europe’s cancer community publishes new report on transforming patient care
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Eli Lilly announces $450m investment in US manufacturing site
- Eli Lilly’s Alzheimer’s drug denied FDA accelerated approval
- Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- JCVI recommends autumn COVID-19 vaccine booster for those at highest risk
- MIT researchers develop AI model to detect future lung cancer risk
- Merging global and local pharmacovigilance operations into a successful integrated approach
- Diversifying Healthcare AI with Federated Learning
- World Health Organization releases latest set of COVID-19 guidelines
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- EU outlines measures to mitigate antibiotic shortage across Europe
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Merging global and local pharmacovigilance operations into a successful integrated approach
PMHub
Healthcare Media Europe – HME Ltd
HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...
Latest intelligence
- Virtual Steering Committee & Peer Influence Program
- In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
- Meeting healthcare’s rising challenges
- The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
- Report gives insights to address gaps in HCP engagement
- How does Pharma-HCP engagement need to evolve in today's digital landscape?...
